Literature DB >> 29935227

EVLP: Ready for Prime Time?

Gabriel Loor1.   

Abstract

Ex vivo lung perfusion implies perfusion and ventilation of a donor lung outside of the human body. The 2 most clinically relevant and commercially available devices currently in clinical trials are XVIVO Perfusion System (XPS Perfusion, Goteborg, Sweden) and Organ Care System (Transmedics, Andover, MA). Our review focuses on the needs met by ex vivo lung perfusion, and the clinical literature on both devices.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  End stage lung disease; Ex vivo lung perfusion; Lung transplantation

Mesh：

Year:  2018        PMID： 29935227     DOI： 10.1053/j.semtcvs.2018.05.005

Source DB:  PubMed          Journal:  Semin Thorac Cardiovasc Surg        ISSN： 1043-0679


  7 in total

Review 1.  Breathing lung transplantation with the Organ Care System (OCS) Lung: lessons learned and future implications.

Authors:  William Lightle; Daoud Daoud; Gabriel Loor
Journal:  J Thorac Dis       Date:  2019-09       Impact factor: 2.895

Review 2.  Ex-vivo lung perfusion therapies: do they add value to organ donation?

Authors:  Amit Lyengar; Alexis Schiazza; Edward Cantu
Journal:  Curr Opin Organ Transplant       Date:  2022-06-01       Impact factor: 2.269

Review 3.  Ex Vivo Lung Perfusion: Current Achievements and Future Directions.

Authors:  Nikhil K Prasad; Chetan Pasrija; Tara Talaie; Alexander S Krupnick; Yunge Zhao; Christine L Lau
Journal:  Transplantation       Date:  2021-05-01       Impact factor: 4.939

4.  Lung Transplantation After Ex Vivo Lung Perfusion Early Outcomes From a US National Registry.

Authors:  Oliver K Jawitz; Vignesh Raman; David Becerra; Julie Doberne; Ashley Y Choi; Samantha E Halpern; Jacob A Klapper; Matthew G Hartwig
Journal:  Ann Surg       Date:  2020-07-24       Impact factor: 13.787

5.  Plasma protein biomarkers for primary graft dysfunction after lung transplantation: a single-center cohort analysis.

Authors:  Lourdes Chacon-Alberty; Rupa S Kanchi; Shengbin Ye; Camila Hochman-Mendez; Daoud Daoud; Cristian Coarfa; Meng Li; Sandra L Grimm; Maher Baz; Ivan Rosas; Gabriel Loor
Journal:  Sci Rep       Date:  2022-09-27       Impact factor: 4.996

6.  Ex-vivo lung perfusion versus standard protocol lung transplantation-mid-term survival and meta-analysis.

Authors:  Adam Chakos; Paule Ferret; Benjamin Muston; Tristan D Yan; David H Tian
Journal:  Ann Cardiothorac Surg       Date:  2020-01

Review 7.  Isolated Lung Perfusion in the Management of Acute Respiratory Distress Syndrome.

Authors:  Nathan Haywood; Matthew R Byler; Aimee Zhang; Mark E Roeser; Irving L Kron; Victor E Laubach
Journal:  Int J Mol Sci       Date:  2020-09-17       Impact factor: 5.923
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.